¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hydatiform mole: types"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® mole ÇÑ±Û ±âÅÂ
¼³¸í   
  »êºÎÀΰú¿¡¼­ ¾²À̴ ¸»·Î½á, ÀӽŽà¹ß»ýÇϴ Å¹ݰú °°Àº Á¶Á÷ÀÇ ºñÁ¤»óÀûÀΠ¼ºÀåÀ¸·Î À¶¸ð¸·»óÇǰ¡ Áõ½ÄÇÏ¿© Æ÷µµÃ³·³ ÀÚ¶ó´Â °ÍÀ¸·Î Æ¯Â¡Áö¾îÁö´Â º´Àû»óŸ¦ ¸»ÇÑ´Ù. ÀÌ º´Àº ±× Á¤µµ¿¡ µû¶ó ¾ç¼º°ú ¾Ç¼ºÀ¸·Î ³ª´©¾î ºÐ·ùÇϰí ÀÖÀ¸¸ç, ¿ª½Ã ÀÌ¿¡ µû¶ó Ä¡·áµµ ´Þ¶óÁø´Ù. ´ë°³ È­Çпä¹ý¿¡ ¹ÝÀÀÀÌ ÁÁ¾Æ ½ÉÇÑ »óŰ¡ ¾Æ´Ï¸é, ¿¹ÈĴ ÁÁÀº ÆíÀÌ´Ù.
¿µ¹® hydatidiform mole ÇÑ±Û Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
¼³¸í   
  Æ÷»ó±âÅ´ À¶¸ðÀÇ ³¶¼ºÆØÃ¢°ú ¿µ¾ç¸ð¼¼Æ÷ÀÇ Áõ½ÄÀ» Æ¯Â¡À¸·Î Çϸç, ¿ÏÀüÇü°ú ºÎºÐÇüÀÌ ÀÖ´Ù. ¿ÏÀüÆ÷µµ¼ÛÀ̱âÅÂ(complete mole)´Â Å¹ÝÀ» ÀÌ·ç´Â ¸ðµç DNA(2n°³)°¡ Á¤ÀڷκÎÅ͸¸ À¯·¡ÇÏ¿© ¹ß»ýÇÑ °Í. ¿°»öü °Ë»ç°á°ú´Â ´ëºÎºÐ 46, XXÀ̰í, ¼Ò¼ö¿¡¼­ 46, XYÀÌ´Ù. Áï ÇÙ DNA°¡ ¾ø°Å³ª ºÒȰ¼ºÈ­µÈ ³­ÀÚ¿¡ 23, X È¤Àº 23, YÀÇ DNA¸¦ °¡Áø µÎ °³ÀÇ Á¤ÀÚ, È¤Àº 46, XX¿Í ÇѰ³ÀÇ Á¤ÀÚ°¡ ¼öÁ¤µÊÀ¸·Î½á Çü¼ºµÇ¸ç ÀÌ Çö»óÀ» ¾Èµå·Î°ÕÁõ(androgenosis)À̶ó ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood mole
    Ç÷¾×±âÅÂ
  • complete hydatidiform mole
    ¿ÏÀüÆ÷»ó±âÅÂ, ¿ÏÀüÆ÷µµ¼ÛÀ̱âÅÂ
  • cystic mole
    Æ÷»ó±âÅÂ
  • destructive mole
    ÆÄ±«±âÅÂ
  • false mole
    °¡¼º±âÅÂ, °ÅÁþ±âÅÂ
  • hydatid mole
    Æ÷»ó±âÅÂ(øàßÒÐô÷Ã), Æ÷µµ¼ÛÀ̱âÅÂ
  • hydatidiform mole
    Æ÷»ó±âÅÂ(øàßÒÐô÷Ã), Æ÷µµ¼ÛÀ̱âÅÂ
  • invasive mole
    ħ½À±âÅÂ, ħÀ±±âÅÂ
  • mole
    1. ±âÅ 2. ¸ô 3. ¸ð¹Ý
  • mole fraction
    ¸ôºÐÀ²
  • partial mole
    ºÎºÐÆ÷»ó±âÅÂ, ºÎºÐÆ÷µµ¼ÛÀ̱âÅÂ
  • vesicular mole
    Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mole
    1.¸ð¹Ý, 2.±âÅÂ, 3. ¸ô
  • complete hydatidiform mole
    ¿ÏÀüÆ÷»ó±âÅÂ, ¿ÏÀüÆ÷µµ¼ÛÀ̱âÅÂ
  • hydatid mole
    Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
  • hydatidiform mole
    (¢¡hydatid mole) Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
  • partial hydatidiform mole
    ºÎºÐÆ÷»ó±âÅÂ, ºÎºÐÆ÷µµ¼ÛÀ̱âÅÂ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • blood mole
    Ç÷¾×±âÅÂ
  • carneous mole
    À°»ó±âÅÂ, °í±â±âÅÂ
  • cystic mole
    (¢¡hydatid mole) Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
  • destructive mole
    ÆÄ±«±âÅÂ
  • false mole
    °¡¼º±âÅÂ, °ÅÁþ±âÅÂ
  • mole fraction
    ¸ôºÐÀ²
  • hydatid mole
    Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
  • hydatidiform mole
    (¢¡hydatid mole) Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
  • invasive mole
    ħÀ±±âÅÂ
  • mole
    ±âÅÂ, ¸ð¹Ý
  • vesicular mole
    (¢¡hydatid mole) Æ÷»ó±âÅÂ, Æ÷µµ¼ÛÀ̱âÅÂ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • B-K mole syndrome
    B-K¸ð¹Ý ÁõÈıº
  • Downey types 1 to 3
    Downey Çü 1-3
  • androgenesis, in h-mole
    ¡­Æ÷»ó±âÅÂ(øàßÒѱ÷Ã)
  • general types of dysmorphia
    ÀϹÝÀÌ»óÇüÅÂÁõÁ¾·ù
  • pigmented mole
    »ö¼Ò¸ð¹Ý(ßäáÈÙ½Úè)
  • pneumocyte, types i and ii
    ÆóÆ÷¼¼Æ÷(øËøàá¬øà), IÇü°ú IIÇü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • general types of dysmorphia
    ÀϹÝÀÌ»óÇüÅÂÁõÁ¾·ù
  • pneumocyte, types i and ii
    ÆóÆ÷¼¼Æ÷(øËøàá¬øà), IÇü°ú IIÇü
  • types of dysmorphia
    ÀÌ»óÇüÅÂÁõÀ¯Çü
  • types of eruption
    ¸ÍÃâÇü(Øðõóúþ).
  • types of placenta
    ŹÝÁ¾·ù
  • androgenesis, in h-mole
    ¡­Æ÷»ó±âÅÂ(øàßÒѱ÷Ã)
  • bk mole
    ºñ-ÄÉÀÌ ¸ð¹Ý(¡­Ù½Úè)
  • blood mole
    Ç÷±âÅÂ(úìÐô÷Ã).
  • carneous mole
    À°ÅÂ(ë¿÷Ã), À°»ó±âÅÂ(ë¿ßÒÐô÷Ã).
  • cystic mole =hydatid
    Æ÷»ó±âÅÂ(øàßÒ Ñ±÷Ã).
  • destructive mole
    ÆÄ±«¼º ±âÅÂ(÷òÎÕàõÐô÷Ã).
  • false mole
    °¡¼º±âÅÂ(¡­Ðô÷Ã).
  • hydatid mole
    Æ÷»ó±âÅÂ(øàßÒÐô÷Ã).
  • hydatidiform mole
    Æ÷»ó±âÅÂ
  • hydatidiform mole
    Æ÷»ó±âÅÂ(¡­Ðô÷Ã).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Types of dysmorphia
    ÀÌ»óÇüÅÂÁõÀ¯Çü
    [¿¾ ¿ë¾î] ÀÌÇüÁõÀ¯Çü
  • GENERAL TYPES OF DYSMORPHIA
    ÀϹÝÀÌ»óÇüÅÂÁõÁ¾·ù
    [¿¾ ¿ë¾î] ÀϹÝÀÌÇüÁõÁ¾·ù
  • Types of placenta
    ŹÝÁ¾·ù
    [¿¾ ¿ë¾î] ŹÝÇü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • gram-mole
    ±×·¥-¸ô
  • mole
    ¸ô
  • mole fraction
    ¸ô ºÐȹ(ÝÂüñ)
  • mole percent
    ¸ô ÆÛ¼¾Æ®
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • invasive mole
    ħ½À¼º±âÅÂ
  • mole
    ±âÅÂ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
H.   1) Hemophilus; È£Ç÷±Õ(¼Ó)
    H. influenzae; ÀÎÇ÷翣ÀÚ È£Ç÷±Õ
  ...
ABO Three Main Blood Types
ASD Atrial Septal Defect
  Types of ASD
  1. Ostium Primum ASD
  ...
EA   1) Esophageal Atresia
  Types
  1. Esophageal Atresia with Dis...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HPV16 human papillomavirus types 16
HTLV-I/II Human T cell lymphotropic virus types I and II
HSV-2 herpes simplex virus types 1 and 2
HTLV-I/II human T lymphotropic virus types I and II
AMS Atypical Mole syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • B-K mole syndrome
    B-K ¸ð¹Ý ÁõÈıº
  • common mole
    ½É»ó ¸ð¹Ý
  • hydatid mole
    Æ÷»ó ±âÅÂ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
hydatiform mole: types <radiology> Complete/classical mole, fertilization of an empty egg; diploid karyotype (paternal XX), no foetal parts; no chorionic membrane, 20% malignant complete mole with coexistent foetus (2%), molar degeneration of an identical twin partial mole, areas of molar change alternating with normal chorionic villi, triploid karyotype (66% XXY; 33% XXX), early onset of preeclampsia, foetal structures present (e.g., placenta), no malignant potential see: hydatiform mole
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hydatiform mole <radiology> Trophoblastic proliferation with avascularity of chorionic villi, marked oedema and enlargement of chorionic villi, severe eclampsia prior to 24 weeks, 1st trimester bleeding, abnormal elevation of beta-hCG, passing grapelike vesicles per vagina, uterus large for dates (50%), hyperechoic intrauterine tissue interspersed with numerous punctate hypoechoic areas (hydropic villi), in 25% atypical appearance: large hyperechoic areas (blood clots) and areas of cystic degeneration; resembles incomplete abortion, thick hyperechoic rim around central anechoic zone, bilateral theca lutein cysts (18-37%) see also: gestational trophoblastic disease, hydatiform mole: types
(12 Dec 1998)
point system test types A near-vision test chart in which the various test types are multiples of a point (1/72 inch), lower-case letters being one-half the designated point size; reading 4-point at 16 inches is normal, and is designated N-4.
(05 Mar 2000)
Snellen's test types Square black symbols employed in testing the acuity of distant vision; the letters vary in size in such a way that each one subtends a visual angle of 5' at a particular distance.
(05 Mar 2000)
stomach cell types <radiology> Parietal (oxyntic), in fundus and body, may lead to HCl (acid) and intrinsic factor, chief, in fundus and body, may lead to pepsinogen, G-cells, in antrum, mucus?
(12 Dec 1998)
oesophageal carcinoma: types <radiology> Histologic types: squamous cell carcinoma (95%), adenocarcinoma (4%), 70% from Barrett oesophagus, carcinosarcoma = pseudosarcoma = spindle cell squamous cell carcinoma, usually middle 1/3 of oesophagus, large, polypoid, smooth, intramural mass; may be pedunculated, mucoepidermoid carcinoma, adenoid cystic carcinoma radiologic types: polypoid/fungating form (most common), sessile/pedunculated tumour with lobulated surface, applecore lesion, ulcerating form, infiltrating form, gradual narrowing with smooth transition (Differential diagnosis: benign stricture), varicoid form: superficial spreading carcinoma, thickened nodular tortuous longitudinal folds (Differential diagnosis: varices)
(12 Dec 1998)
test types Letters of various sizes used to test visual acuity.
(05 Mar 2000)
Jaeger's test types Type of different sizes used for testing the acuity of near vision.
(05 Mar 2000)
blood mole A uterine mass occurring after foetal death and consisting of blood clots, foetal membranes, and placenta.
Synonym: blood mole, carneous mole.
(05 Mar 2000)
Breus mole An aborted ovum in which the foetal surface of the placenta presents numerous haematomata with an absence of blood vessels in the chorion and an ovum much smaller in size than normal in relation to the duration of the pregnancy.
(05 Mar 2000)
carneous mole A uterine mass occurring after foetal death and consisting of blood clots, foetal membranes, and placenta.
Synonym: blood mole, carneous mole.
(05 Mar 2000)
malignant mole syndrome <syndrome> Irregularly shaped, variously coloured, distinctively melanocytic, 5 to 10 mm nevi occurring in large numbers (to over 100) primarily on the trunk and extremities, with a high risk of malignancy reported in several members and three generations of a family.
(05 Mar 2000)
vesicular mole <gynaecology, oncology, tumour> A relatively rare mass or tumour that can form within the uterus at the beginning of a pregnancy. The cause of hydatidiform mole is unknown.
Symptoms include vaginal bleeding, uterine growth, nausea and vomiting. Some hydatidiform moles may become malignant (cancerous) where they are referred to as a choriocarcinoma.
Incidence: 1 in 1,500 births.
(02 Jan 1998)
grape mole <gynaecology, oncology, tumour> A relatively rare mass or tumour that can form within the uterus at the beginning of a pregnancy. The cause of hydatidiform mole is unknown.
Symptoms include vaginal bleeding, uterine growth, nausea and vomiting. Some hydatidiform moles may become malignant (cancerous) where they are referred to as a choriocarcinoma.
Incidence: 1 in 1,500 births.
(02 Jan 1998)
mole <dermatology> A benign pigmented skin lesion or nevus.
(27 Sep 1997)
mole fraction The ratio of the moles of one component of a system to the total moles of all the components present.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mole cricket
    ¶¥°­¾ÆÁö
  • mole plow
    ÁöÇÏ ¾Ï°Å ±¼Âø±â
  • mole rat
    µÚÁö
  • mole shrew
    µÎ´õÁö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á